Health Condition 1: D509- Iron deficiency anemia, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: · Patients having mild (10.0-11.9 g/dL) to moderate (7.0-9.9 g/dL ) Anaemia · Patients of either sex in the age group 18-65 years. · Patients not taking any other drugs for SÅ«â?? al-Qinya (Anaemia)
Exclusion criteria
Exclusion criteria: 1. Pregnant and lactating women 2. Patients having severe Anaemia (below 7gm/dl) 3. Patients having occult blood positive on stool examination. 4. Patients with chronic diseases requiring long-term treatment such as DM, T.B., HIV infection, leukemia, endocrine disorders, Haemorrhagic diathesis (hemophilia, ITP), bleeding piles, menorrhagia, metrorrhagia or any other serious and/or unstable illness that, in the opinion of the investigator, could constitute a risk when taking study drug or could interfere with the interpretation of data. 5. Patients with concurrent serious hepatic, cardiac, renal or pulmonary dysfunction. 6. Patients not willing to report for follow up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement in signs and symptoms of SÅ«â?? al-Qinya (Anaemia)Timepoint: 12 weeks. | — |
Secondary
| Measure | Time frame |
|---|---|
| Haematological and biochemical assessment for safety assessmentTimepoint: Investigations will be done at baseline and end of treatment | — |
Countries
India
Contacts
Central Council for Research in Unani Medicine (CCRUM)